BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23810893)

  • 1. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
    Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
    J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β
    Schobesberger S; Wright PT; Poulet C; Sanchez Alonso Mardones JL; Mansfield C; Friebe A; Harding SE; Balligand JL; Nikolaev VO; Gorelik J
    Elife; 2020 Mar; 9():. PubMed ID: 32228862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2016 Feb; 91():215-27. PubMed ID: 26773602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Phosphodiesterase 1 in the Regulation of Real-Time cGMP Levels and Contractility in Adult Mouse Cardiomyocytes.
    Bork NI; Subramanian H; Kurelic R; Nikolaev VO; Rybalkin SD
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local response of L-type Ca(2+) current to nitric oxide in frog ventricular myocytes.
    Dittrich M; Jurevicius J; Georget M; Rochais F; Fleischmann B; Hescheler J; Fischmeister R
    J Physiol; 2001 Jul; 534(Pt 1):109-21. PubMed ID: 11432996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic Peptide Receptor B Protects Against Atrial Fibrillation by Controlling Atrial cAMP Via Phosphodiesterase 2.
    Dorey TW; Liu Y; Jansen HJ; Bohne LJ; Mackasey M; Atkinson L; Prasai S; Belke DD; Fatehi-Hassanabad A; Fedak PWM; Rose RA
    Circ Arrhythm Electrophysiol; 2023 Nov; 16(11):e012199. PubMed ID: 37933567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtubule-Mediated Regulation of β
    Kwan Z; Paulose Nadappuram B; Leung MM; Mohagaonkar S; Li A; Amaradasa KS; Chen J; Rothery S; Kibreab I; Fu J; Sanchez-Alonso JL; Mansfield CA; Subramanian H; Kondrashov A; Wright PT; Swiatlowska P; Nikolaev VO; Wojciak-Stothard B; Ivanov AP; Edel JB; Gorelik J
    Circ Res; 2023 Nov; 133(11):944-958. PubMed ID: 37869877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Implications for PDE2 and cGMP/cAMP Mediated Crosstalk in Cardiovascular Diseases.
    Sadek MS; Cachorro E; El-Armouche A; Kämmerer S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasticity of surface structures and β(2)-adrenergic receptor localization in failing ventricular cardiomyocytes during recovery from heart failure.
    Lyon AR; Nikolaev VO; Miragoli M; Sikkel MB; Paur H; Benard L; Hulot JS; Kohlbrenner E; Hajjar RJ; Peters NS; Korchev YE; Macleod KT; Harding SE; Gorelik J
    Circ Heart Fail; 2012 May; 5(3):357-65. PubMed ID: 22456061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes.
    Brinks H; Rohde D; Voelkers M; Qiu G; Pleger ST; Herzog N; Rabinowitz J; Ruhparwar A; Silvestry S; Lerchenmüller C; Mather PJ; Eckhart AD; Katus HA; Carrel T; Koch WJ; Most P
    J Am Coll Cardiol; 2011 Aug; 58(9):966-73. PubMed ID: 21851887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of PDE2 and PDE5 by specific GAF ligands: delayed activation of PDE5.
    Jäger R; Schwede F; Genieser HG; Koesling D; Russwurm M
    Br J Pharmacol; 2010 Dec; 161(7):1645-60. PubMed ID: 20698857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired β-adrenergic responsiveness accentuates dysfunctional excitation-contraction coupling in an ovine model of tachypacing-induced heart failure.
    Briston SJ; Caldwell JL; Horn MA; Clarke JD; Richards MA; Greensmith DJ; Graham HK; Hall MC; Eisner DA; Dibb KM; Trafford AW
    J Physiol; 2011 Mar; 589(Pt 6):1367-82. PubMed ID: 21242250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDE4D mediates impaired β-adrenergic receptor signalling in the sinoatrial node in mice with hypertensive heart disease.
    Dorey TW; McRae MD; Belke DD; Rose RA
    Cardiovasc Res; 2023 Dec; 119(17):2697-2711. PubMed ID: 37643895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Adrenergic signaling drives structural and functional maturation of mouse cardiomyocytes.
    Eliezeck M; Guedes Jesus IC; Scalzo SA; Sanches BL; Silva KSC; Costa M; Mesquita T; Rocha-Resende C; Szawka RE; Guatimosim S
    Am J Physiol Cell Physiol; 2024 May; 326(5):C1334-C1344. PubMed ID: 38557356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the control of basal L-type Ca(2+) current by the cyclic AMP signaling cascade in frog, rat, and human cardiac myocytes.
    Treinys R; Bogdelis A; Rimkutė L; Jurevičius J; Skeberdis VA
    J Physiol Sci; 2016 Jul; 66(4):327-36. PubMed ID: 26676115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 Knock-Out in Primary Neonatal and Adult Cardiomyocytes Reveals Distinct cAMP Dynamics Regulation by Various PDE2A and PDE3A Isoforms.
    Skryabin EB; De Jong KA; Subramanian H; Bork NI; Froese A; Skryabin BV; Nikolaev VO
    Cells; 2023 Jun; 12(11):. PubMed ID: 37296663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AKAP12 Upregulation Associates With PDE8A to Accelerate Cardiac Dysfunction.
    Qasim H; Rajaei M; Xu Y; Reyes-Alcaraz A; Abdelnasser HY; Stewart MD; Lahiri SK; Wehrens XHT; McConnell BK
    Circ Res; 2024 Apr; 134(8):1006-1022. PubMed ID: 38506047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compartmentation of cGMP Signaling in Induced Pluripotent Stem Cell Derived Cardiomyocytes during Prolonged Culture.
    Faleeva M; Diakonov I; Srivastava P; Ramuz M; Calamera G; Andressen KW; Bork N; Tsansizi L; Cosson MV; Bernardo AS; Nikolaev V; Gorelik J
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Inhibition of Phosphodiesterase-5 and -9 in Experimental Heart Failure.
    Rademaker MT; Scott NJA; Charles CJ; Richards AM
    JACC Heart Fail; 2024 Jan; 12(1):100-113. PubMed ID: 37921801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.